Patents by Inventor Mark Pittenger

Mark Pittenger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080095749
    Abstract: Methods of treating autoimmune diseases, allergic responses, cancer, inflammatory diseases, or fibrosis in an animal, promoting would healing, repairing epithelial damage and promoting angiogenesis in an organ or tissue of an animal by administering to the animal mesenchymal stem cells in an effective amount.
    Type: Application
    Filed: March 22, 2007
    Publication date: April 24, 2008
    Inventors: Sudeepta Aggarwal, Mark Pittenger, Timothy Varney, Alla Danilkovitch
  • Publication number: 20070003530
    Abstract: Disclosed is a method for producing cardiomyocytes in vivo by administering to the heart of an individual a cardiomyocyte producing amount of mesenchymal stem cells. These cells can be administered as a liquid injectible or as a preparation of cells in a matrix which is or becomes solid or semi-solid. The cells can be genetically modified to enhance myocardial differentiation and integration. Also disclosed is a method for replacing cells ex vivo in a heart valve for implantation.
    Type: Application
    Filed: June 23, 2006
    Publication date: January 4, 2007
    Inventors: Mark Pittenger, Stephen Gordon, Alastair Mackay, Bradley Martin
  • Publication number: 20050239897
    Abstract: Methods of treating autoimmune diseases, allergic responses, cancer, or inflammatory diseases in an animal, promoting would healing, and promoting angiogenesis in an organ or tissue of an animal by administering to the animal mesenchymal stem cells in an effective amount.
    Type: Application
    Filed: March 15, 2005
    Publication date: October 27, 2005
    Inventors: Mark Pittenger, Sudeepta Aggarwal
  • Publication number: 20050112104
    Abstract: Disclosed is a method for producing cardiomyocytes in vivo by administering to the heart of an individual a cardiomyocyte producing amount of mesenchymal stem cells. These cells can be administered as a liquid injectible or as a preparation of cells in a matrix which is or becomes solid or semi-solid. The cells can be genetically modified to enhance myocardial differentiation and integration. Also disclosed is a method for replacing cells ex vivo in a heart valve for implantation.
    Type: Application
    Filed: October 21, 2003
    Publication date: May 26, 2005
    Inventors: Mark Pittenger, Stephen Gordon, Alastair MacKay, Bradley Martin